Jury members (from right) Sanjaya Baru, Omkar Goswami, R. Jagannathan; with Outlook Editor-in-Chief Rajesh Ramachandran and colleagues Arindam Mukherjee, Lola Nayar and Arushi Be...
Outlook previously detailed the unscrupulous ways in which medical device manufacturing companies and hospitals fleece patients into getting expensive surgeries and transplants to make money
MicroPort, which entered India after price control regime was put in place, is being probed for registering its Indian distributors as importers or manufacturers
Outlook earlier reported that hospitals and device manufacturers had withdrawn high end stents from shelves, creating artificial shortage of supply of stents available to patients.
